share_log

港股异动 | 心通医疗-B(02160)涨超7% 预计去年收入同比增长约31%至36%

Changes in Hong Kong stocks | Xintong Medical-B (02160) rose more than 7% and is expected to increase revenue by about 31% to 36% year-on-year last year

Zhitong Finance ·  Feb 29 01:45

Xintong Medical-B (02160) rose more than 7%. As of press release, it rose 7.46% to HK$1.44, with a turnover of HK$3.685,400.

The Zhitong Finance App learned that Xintong Medical-B (02160) rose by more than 7%. As of press release, it had risen 7.46% to HK$1.44, with a turnover of HK$3.685,400.

According to the news, Xintong Medical announced that the Group expects revenue of RMB 330 million to RMB 340 million for the year ended December 31, 2023, an increase of about 31% to 36% over the revenue of RMB 251 million for the year ended December 31, 2022. Revenue growth is mainly due to continued progress in the admission of transcatheter aortic valve implantation TAVI products in China, driving rapid increases in implantation volume and revenue, as well as overseas market expansion and revenue growth.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment